Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
43 hedge funds and large institutions have $58.7M invested in Lumos Pharma, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 9 closing their positions.
111% more capital invested
Capital invested by funds: $27.9M → $58.7M (+$30.9M)
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
7% less funds holding
Funds holding: 46 → 43 (-3)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
90% less call options, than puts
Call options by funds: $313K | Put options by funds: $3.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.01M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$960K |
| 3 |
IFG
Investors Financial Group
Plymouth,
Minnesota
|
+$631K |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$595K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$429K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$321K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$178K |
| 3 |
Renaissance Technologies
New York
|
-$46.4K |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$24K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13.9K |
LUMO Hedge Fund Activity: Q2 2020 in Review
43 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2020, worth a combined $58.7M — up 111% from $27.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LUMO and 6 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 10 added.
The largest buyer was Wells Fargo, adding an estimated $1.01M. The largest seller was Millennium Management, exiting entirely with an estimated $321K sold.
- 43 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2020, down from 46 in Q1 2020.
- Funds reported $58.7M of Lumos Pharma, Inc. Common Stock stock for Q2 2020, up 111% quarter-over-quarter.
- 6 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2020 and 9 closed out, a net change of -3 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q2 2020 was Wells Fargo, an estimated $1.01M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q2 2020 was Millennium Management, an estimated $321K sold.
Based on aggregated 13F filings for Q2 2020.